Barclays raised the firm’s price target on Bunge (BG) to $135 from $120 and keeps an Overweight rating on the shares. The company reported a strong Q4 but issued a cautious outlook as biofuel policy remains uncertain, the analyst tells investors in a research note. Barclays continues to believe in the synergies from the Viterra merger.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BG: